Increased storage and secretion of islet amyloid polypeptide relative to insulin in the spontaneously diabetic GK rat

Pancreas

Volumn 13, Issue 3, 1996, Pages 259-267

  Leckstrom A ^a   Ostenson C G ^d   Efendic S ^d   Arnelo, U ^a   Permert, J ^b   Lundquist, I ^c   Westermark, P ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Glucose tolerance test; Goto Kakizaki rat; Immunocytochemistry; Insulin; Islet amyloid polypeptide; Plasma hormone levels

Indexed keywords

AMYLIN; GLUCOSE; INSULIN;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLUCOSE TOLERANCE TEST; IMMUNOCYTOCHEMISTRY; INSULIN BLOOD LEVEL; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN SECRETION; RAT;

EID: 0029848461     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199610000-00008     Document Type: Article

References (55)

1. Westermark P, Wernstedt C, Wilander E, Sletten K. A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun 1986;140:827-31.
2. Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 1987;84:3881-5.
3. Westermark P, Wernstedt C, O'Brien TD, Hayden DW, Johnson KH. Islet amyloid in type 2 diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Pathol 1987;127:414-7.
4. Cooper GJS, Willis AC, Clark A, Turner RC, Sim SB, Reid KBM. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA 1987;84:8628-32.
5. Kanatsuka A, Makino H, Ohsawa H, et al. Secretion of islet amyloid polypeptide in response to glucose. FEBS Lett 1989;259:199-201.
6. Fehmann HC, Weber V, Göke R, Göke B, Arnold R. Cosecretion of amylin and insulin from isolated rat pancreas. FEBS Lett 1990;262:279-81.
7. Kahn SE, D'Alessio DD, Schwartz MW, et al. Evidence of cosecretion of islet amyloid polypeptide and insulin by β-cells. Diabetes 1990;39:634-8.
8. Hartter E, Svoboda T, Ludvik B, et al. Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans. Diabetologia 1991;32:52-4.
9. Nakazato M, Miyazato M, Asai J, et al. Islet amyloid polypeptide, a novel pancreatic peptide, is a circulating hormone secreted under glucose stimulation. Biochem Biophys Res Commun 1990;169:713-8.
10. Inoue K, Hisatomi A, Umeda F, Nawata H. Relative hypersecretion of amylin to insulin from rat pancreas after neonatal STZ treatment. Diabetes 1992;41:723-7.
11. Sanke T, Hanabusa T, Nakano Y, et al. Plasma islet amyloid polypeptide (amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991;34:129-32.
12. Hothersall JS, Muirhead RP, Wimalawansa S. The effect of amylin and calcitonin gene-related peptide on insulin-stimulated glucose transport in the diaphragm. Biochem Biophys Res Commun 1990;169:451-4.
13. Zierath JR, Galuska D, Engström Å, et al. Human islet amyloid polypeptide at pharmacological levels inhibits insulin and phorbol esterstimulated glucose transport in in vitro incubated human muscle strips. Diabetologia 1992;35:26-31.
14. Frontoni S, Bong Choi S, Banduch D, Rossetti L. In vivo insulin resistance induced by amylin primarily through inhibition of insulin-stimulated glycogen synthesis in skeletal muscle. Diabetes 1991;40:568-73.
15. Deems RO, Deacon RW, Young DA. Amylin activates glycogen phosphorylase and inactivates glycogen synthase via a cAMP-independent mechanism. Biochem Biophys Res Commun 1991;174:716-20.
16. Young AA, Mott DM, Stone K, Cooper GJS. Amylin activates glycogen phosphorylase in the isolated soleus muscle of the rat. FEBS Lett 1991;281:149-51.
17. Porte D Jr. β-cells in type II diabetes mellitus. Diabetes 1991;40:166-80.
18. Cooper GJS. Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease. Endocr Rev 1994;15:163-201.
19. Panagiotidis G, Salchi AA, Westermark P, Lundquist I. Homologous islet amyloid polypeptide: effects on plasma levels of glucagon, insulin and glucose in the mouse. Diab Res Clin Pract 1992;18:167-71.
20. Åkesson B, Panagiotidis G, Westermark P, Lundquist I. The nature of the stimulus determines the effects of IAPP on islet hormone release. Pharmacol Toxicol 1995;suppl IV:76.
21. Johnson KH, O'Brien TD, Betsholtz C, Westermark P. Islet amyloid, islet amyloid polypeptide, and diabetes mellitus. N Engl J Med 1989;321:513-8.
22. Nishi M, Sanke T, Nagamatsu S, Bell GI, Steiner DF. Islet amyloid polypeptide. A new β-cell secretory product related to islet amyloid deposits. J Biol Chem 1990;265:4173-6.
23. Edwards BJ, Morley JE. Amylin. Life Sci 1992;51:1899-912.
24. Eriksson J, Nakazato M, Miyazato M, Shiomi K, Matsukura S, Groop L. Islet amyloid polypeptide plasma concentrations in individuals at increased risk of developing Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992;35:291-3.
25. Groop LC, Eriksson JG. The etiology and pathogenesis of non-insulin-dependent diabetes. Ann Med 1992;24:483-9.
26. Luskey KL. Possible links between amylin and diabetes. Diabetes Care 1992;41:297-9.
27. Westermark P, Johnson KH, O'Brien TD, Betsholtz C. Islet amyloid polypeptide - a novel controversy in diabetes research. Diabetologia 1992;35:1-7.
28. Wolffenbuttel BHR, Van Haeften TW. Non-insulin dependent diabetes mellitus: defects in insulin secretion. Eur J Clin Invest 1993;23:69-79.
29. Kimura K, Toyota T, Kakizaki M, Kudo M, Takebe K, Goto Y. Impaired insulin secretion in the spontaneous diabetic rat. Tohoku J Exp Med 1982;137:453-9.
30. Goto Y, Suzuki K, Sasaki M, Ono T, Abe S. GK rat as a model of nonobese, noninsulin-dependent diabetes: selective breeding over 35 generations. In: Schafrir E, Renold AE, eds. Frontiers in diabetes research. Lessons from animal diabetes II. London: John Libbey, 1988:301-3.
31. Portha B, Serradas P, Bailbe D, Suzuki K, Goto Y, Giroix M. β-cell insensitivity to glucose in the GK rat, a spontaneous nonobese model for type II diabetes. Diabetes 1991;40: 486-91.
32. Östenson C-G, Khan A, Abdel-Halim SM, et al. Abnormal insulin secretion and glucose metabolism in pancreatic islets from the spontaneously diabetic GK rat. Diabetologia 1993; 36:3-8.
33. Goto Y, Kakizaki M, Toyota T, et al. Spontaneous diabetes produced by repeated selective breeding of normal Wistar rats. In: Bajaj JS, ed. Diabetes. Amsterdam: Excerpta Medica, 1977:703-10.
34. Hughes SJ, Suzuki K, Goto Y. The role of islet secretory function in the development of diabetes in the GK Wistar rat. Diabetologia 1994;37:863-70.
35. Ohneda M, Johnson JH, Inman LR, et al. GLUT2 expression and function in β-cells of GK rats with NIDDM. Diabetes 1993;42:1065-72.
36. Giroix M, Vesco L, Portha B. Functional and metabolic perturbations in isolated pancreatic islets from the GK rat, a genetic model of noninsulin-dependent diabetes. Endocrinology 1993;132:815-22.
37. Goto Y, Suzuki K, Ono T, Sasaki M, Toyota T. Development of diabetes in the non-obese NIDDM rat (GK rat). Adv Exp Med Biol 1988;246:29-31.
38. Goto Y, Kakizaki M. The spontaneous-diabetic rat: a model of noninsulin dependent diabetes mellitus. Proc Jpn Acad 1981;57:381-4.
39. Sternberger LA. The unlabelled antibody peroxidase-antiperoxidase (PAP) method. In: Sternberger LA, ed. Immunohistochemistry. New York: Wiley, 1979:104-67.
40. Christmanson L, Betsholtz C, Leckström A, et al. Islet amyloid polypeptide in the rabbit and European hare: studies on its relationship to amyloidogenesis. Diabetologia 1993;36: 183-8.
41. Westermark P, Wilander E. Islet amyloid in type 2 (non-insulin-dependent) diabetes is related to insulin. Diabetologia 1983;24:342-6.
42. Herbert W, Lau KS, Gottlieb CW, Bleicher SJ. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 1965; 25:1375-84.
43. Warren S, LeCompte PM, Legg MA. Qualitative pancreatic changes in diabetes mellitus. Fibrosis. In: Warren S, LeCompte PM, Legg MA, eds. The pathology of diabetes mellitus. Philadelphia: Lea & Febiger, 1966:64-5.
44. Abdel-Halim SM, Guenifi A, Efendic S, Östenson C-G. Both somatostatin and insulin responses to glucose are impaired in the perfused pancreas of the spontaneously noninsulin-dependent diabetic GK (Goto-Kakizaki) rats. Acta Physiol Scand 1993;148:219-26.
45. Östenson C-G, Abdel-Halim SM, Rasschaert J, et al. Deficient activity of FAD-linked glycerophosphate dehydrogenase in islets of GK rats. Diabetologia 1993;36:722-6.
46. Suzuki K, Goto Y. Non-insulin dependent diabetes mellitus in GK rats. Prog Diab Mell Res 1987;22:211-7.
47. Jamal H, Bretherton-Watt D, Suda K, Ghatei MA, Bloom SR. Islet amyloid polypeptide-like immunoreactivity (amylin) in rats treated with dexamethasone and streptozotocin. J Endocrinol 1990;126:425-9.
48. Stridsberg M, Sandler S, Wilander E. Cosecretion of islet amyloid polypeptide (IAPP) and insulin from isolated rat pancreatic islets following stimulation or inhibition of β-cell function. Regul Pept 1993;45:363-70.
49. Hiramatsu S, Inoue K, Sako Y, Umeda F, Nawata H. Insulin treatment improves relative hypersecretion of amylin to insulin in rats with noninsulin-dependent diabetes mellitus induced by neonatal sreptozocin injection. Metabolism 1994;43:766-70.
50. Pieber TR, Roitelman J, Lee Y, Luskey KL, Stein DT. Direct plasma radioimmunoassay for rat amylin-(1-37): concentrations with acquired and genetic obesity. Am J Physiol 1994;267:E156-64.
51. Inoue K, Hiramatsu S, Hisatomi A, Umeda F, Nawata H. Hypersecretion of amylin from the perfused pancreas of genetically obese (fa/fa) rats and its alteration with aging. Metabolism 1993;42:654-8.
52. Bisbis S, Bailbe D, Tormo M-A, et al. Insulin resistance in the GK rat: decreased receptor number but normal kinase activity in liver. Am J Physiol 1993;265:E807-13.
53. Silvestre RA, Peiró E, Dégano P, Miralles P, Marco J. Inhibitory effect of rat amylin on the insulin responses to glucose and arginine in the perfused rat pancreas. Regul Pept 1990;31:23-31.
54. Kogire M, Ishizuka J, Thompson JC, Greeley Jr GH. Inhibitory action of islet amyloid polypeptide and calcitonin gene-related peptide on release of insulin from the isolated rat pancreas. Pancreas 1991;6:459-63.
55. Blackard WG, Clore JN, Kellum JM. Amylin/insulin secretory ratios in morbidly obese man: inverse relationship with glucose disappearance rate. J Clin Endocrinol Metab 1994; 78:1257-60.